September 2020, by Cormac Sheridan
August 2020, by Cormac Sheridan Read the full article here.
February 2020, by Michael Flanagan
February 2020, by Cormac Sheridan
Article in BioCentury Innovation: Adrenomed looks beyond immune modulators for sepsis, aims for shock prevention
October 2019, by Lauren Martz and Inhua Muijrers-Chen, Associate Editors
Article in GoingPublic Special Issue: Case Study “Mit einem gefäßschützenden Antikörper gegen septischen Shock”
Read the full article about Adrenomed on page 104 of the GoingPublic Special Issue “Biotechnologie 2019” (Article in German). Illustration: Adrenomed AG
Article in BioWorld: Adrenomed readies for success as lead drug adrecizumab clears interim hurdle in sepsis trial
April 2019 by Cormac Sheridan, Staff Writer.
Published in the January 2019 edition of MedNous, a publication of Evernow Publishing Ltd.
Article in ENDPOINTS: Wellington, HBM lead €24M round as Adrenomed preps septic shock treatment for human testing
November 2018 by Amber Tong. Go to the article